Beyond Air, Inc. XAIR 深 沪
已收盘 02-13 16:00:00 美东时间
1.05
+0.030
+2.94%
华盛通- 最 高1.15
- 今 开1.05
- 成交量 58.05万股
- 最 低 1.00
- 昨 收 1.02
- 总市值 1105.58万
- 52周最高 7.126
- 市盈率 静 --
- 换手率 5.51%
- 52周最低 0.6733
- 委 比 77.82%
- 总股本 1052.93万
- 历史最高 328.20
- 量 比 1.91
- 振 幅 14.71%
- 历史最低 0.7311
- 每 手 1
- 风险率 1.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Beyond Air Reports Strong Q3 Growth and Funding Extension
The latest announcement is out from Beyond Air ( ($XAIR) ). On February 13, 202...
今天 05:52
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers CytoMed Therapeutics (NASDAQ:GDTC) shares moved upwards by 6.9% to $1....
今天 05:06
Beyond Air Affirms FY2026 Sales Guidance of $8.000M-$10.000M
Beyond Air (NASDAQ:XAIR) affirms FY2026 sales outlook from $8.000 million-$10.000 million to $8.000 million-$10.000 million.
02-13 20:44
Insights into Beyond Air Q3 Earnings
The Q3 earnings report for Beyond Air (NASDAQ:XAIR) was released on Friday, Feb...
02-13 20:42
Beyond Air Q3 EPS $(0.85) Misses $(0.74) Estimate, Sales $2.194M Beat $2.146M Estimate
Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.74) by 14.4 percent. This is a 71.67 percent increase over losses of $(3.00) per share from the
02-13 20:39
Earnings Scheduled For February 13, 2026
Companies Reporting Before The Bell • MISTRAS Group (NYSE:MG) is expected to re...
02-13 19:11
Beyond Air Earnings Preview
Beyond Air (NASDAQ:XAIR) is preparing to release its quarterly earnings on Frid...
02-12 23:01
XTL Update on Recent Developments
XTL Biopharmaceuticals Ltd. is working to finalize the acquisition of 85% of NeuroNOS Ltd. from Beyond Air Inc., following a binding letter of intent signed on January 13, 2026. The company plans to hold a shareholders' meeting on February 17, 2026, to approve a private placement of up to $2 million. The transaction and private placement aim to address the company's deficiency under Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5...
01-29 21:05
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast
Beyond Air Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company, will report its third fiscal quarter 2025 financial results on February 13, 2026. A conference call and webcast will be held at 8:00 am ET that day. The call can be accessed domestically via 1-877-407-0784 or internationally via 1-201-689-8560 using conference ID 13758405. A webcast will also be available on the company’s website, with a replay one hour post-call. Bey...
01-26 21:05
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) received a notification from Nasdaq stating it doesn't meet the minimum $2.5 million stockholders' equity requirement for continued listing. The company reported a stockholders' equity deficit of $47,000 as of June 30, 2025, and doesn't meet alternatives for market value or net income. Nasdaq did not delist the company's ADSs immediately but gave XTL until March 6, 2026, to submit a compliance plan, with...
01-23 21:10
